REG - Haleon PLC - Notice of Annual General Meeting (AGM)

HALEONAnnouncement

04/04/2025 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250404:nRSD7691Da&default-theme=true

RNS Number : 7691D  Haleon PLC  04 April 2025

 

Haleon plc: Notice of Annual General Meeting (AGM)

 

4 April 2025: Haleon plc (the "Company" or "Haleon") today announces that the
following documents have been made available to shareholders:

 

1.  Notice of 2025 Annual General Meeting (the "Notice");

2.  Form of Proxy for 2025 Annual General Meeting; and

3.  AGM Voting Instruction Card.

 

Haleon's AGM will again be a virtual meeting, broadcast under studio
conditions from the Company's London offices at 3.00pm (BST) on Wednesday 28
May 2025. The Notice is available on the Company's website at
https://www.haleon.com/investors/shareholder-information/annual-general-meetings
(https://www.haleon.com/investors/shareholder-information/annual-general-meetings)
, and includes full details of the business to be conducted and joining
instructions.

In compliance with UK Listing Rule 6.4.1R, a copy of the above documents has
been submitted to the National Storage Mechanism and will shortly be available
for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

Amanda Mellor

Company Secretary

 

Enquiries

 

 Investors                                                                         Media

 Jo Russell                               +44 7787 392441                          Zoë Bird                              +44 7736 746167
 Rakesh Patel                             +44 7552 484646                          Victoria Durman                       +44 7894 505730
 Emma White                               +44 7823 523562

 Email: investor-relations@haleon.com (mailto:investor-relations@haleon.com)       Email: corporate.media@haleon.com (mailto:corporate.media@haleon.com)

 

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans five major categories - Oral Health, Pain Relief, Respiratory Health,
Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu,
Otrivin, Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAUPUCWCUPAGWC